BlackRock’s Poseida Therapeutics, Inc. Common Stock PSTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $54.1M | Buy |
|
|||||
|
2024
Q3 | $14.7M | Buy |
|
|||||
|
2024
Q2 | $14.3M | Sell |
|
|||||
|
2024
Q1 | $15.8M | Sell |
|
|||||
|
2023
Q4 | $16.9M | Sell |
|
|||||
|
2023
Q3 | $12M | Sell |
|
|||||
|
2023
Q2 | $9.12M | Buy |
|
|||||
|
2023
Q1 | $5.82M | Buy |
|
|||||
|
2022
Q4 | $9.11M | Buy |
|
|||||
|
2022
Q3 | $5.11M | Buy |
|
|||||
|
2022
Q2 | $2.88M | Sell |
|
|||||
|
2022
Q1 | $11.1M | Sell |
|
|||||
|
2021
Q4 | $17.4M | Buy |
|
|||||
|
2021
Q3 | $18.5M | Sell |
|
|||||
|
2021
Q2 | $25.5M | Sell |
|
|||||
|
2021
Q1 | $27M | Buy |
|
|||||
|
2020
Q4 | $17M | Buy |
|
|||||
|
2020
Q3 | $8.47M | Buy |
|